Ferroptosis in inflammatory arthritis: A promising future

Ferroptosis is a kind of regulatory cell death (RCD) caused by iron accumulation and lipid peroxidation, which is characterized by mitochondrial morphological changes and has a complex regulatory network. Ferroptosis has been gradually emphasized in the pathogenesis of inflammatory arthritis. In thi...

Full description

Bibliographic Details
Main Authors: Siyuan Chang, Mengshi Tang, Bikui Zhang, Daxiong Xiang, Fen Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.955069/full
_version_ 1811221822801182720
author Siyuan Chang
Mengshi Tang
Bikui Zhang
Daxiong Xiang
Fen Li
author_facet Siyuan Chang
Mengshi Tang
Bikui Zhang
Daxiong Xiang
Fen Li
author_sort Siyuan Chang
collection DOAJ
description Ferroptosis is a kind of regulatory cell death (RCD) caused by iron accumulation and lipid peroxidation, which is characterized by mitochondrial morphological changes and has a complex regulatory network. Ferroptosis has been gradually emphasized in the pathogenesis of inflammatory arthritis. In this review, we summarized the relevant research on ferroptosis in various inflammatory arthritis including rheumatoid arthritis (RA), osteoarthritis, gout arthritis, and ankylosing spondylitis, and focused on the relationship between RA and ferroptosis. In patients with RA and animal models of RA, there was evidence of iron overload and lipid peroxidation, as well as mitochondrial dysfunction that may be associated with ferroptosis. Ferroptosis inducers have shown good application prospects in tumor therapy, and some anti-rheumatic drugs such as methotrexate and sulfasalazine have been shown to have ferroptosis modulating effects. These phenomena suggest that the role of ferroptosis in the pathogenesis of inflammatory arthritis will be worth further study. The development of therapeutic strategies targeting ferroptosis for patients with inflammatory arthritis may be a promising future.
first_indexed 2024-04-12T08:05:47Z
format Article
id doaj.art-7d9c3afd966b43a78854a1fc6700fd53
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T08:05:47Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-7d9c3afd966b43a78854a1fc6700fd532022-12-22T03:41:10ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-07-011310.3389/fimmu.2022.955069955069Ferroptosis in inflammatory arthritis: A promising futureSiyuan Chang0Mengshi Tang1Bikui Zhang2Daxiong Xiang3Fen Li4Department of Rheumatology and Immunology, The Second Xiangya Hospital of Central South University, Changsha, ChinaDepartment of Rheumatology and Immunology, The Second Xiangya Hospital of Central South University, Changsha, ChinaDepartment of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, ChinaDepartment of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, ChinaDepartment of Rheumatology and Immunology, The Second Xiangya Hospital of Central South University, Changsha, ChinaFerroptosis is a kind of regulatory cell death (RCD) caused by iron accumulation and lipid peroxidation, which is characterized by mitochondrial morphological changes and has a complex regulatory network. Ferroptosis has been gradually emphasized in the pathogenesis of inflammatory arthritis. In this review, we summarized the relevant research on ferroptosis in various inflammatory arthritis including rheumatoid arthritis (RA), osteoarthritis, gout arthritis, and ankylosing spondylitis, and focused on the relationship between RA and ferroptosis. In patients with RA and animal models of RA, there was evidence of iron overload and lipid peroxidation, as well as mitochondrial dysfunction that may be associated with ferroptosis. Ferroptosis inducers have shown good application prospects in tumor therapy, and some anti-rheumatic drugs such as methotrexate and sulfasalazine have been shown to have ferroptosis modulating effects. These phenomena suggest that the role of ferroptosis in the pathogenesis of inflammatory arthritis will be worth further study. The development of therapeutic strategies targeting ferroptosis for patients with inflammatory arthritis may be a promising future.https://www.frontiersin.org/articles/10.3389/fimmu.2022.955069/fullferroptosisinflammatory arthritisiron accumulationlipid peroxidationcell death
spellingShingle Siyuan Chang
Mengshi Tang
Bikui Zhang
Daxiong Xiang
Fen Li
Ferroptosis in inflammatory arthritis: A promising future
Frontiers in Immunology
ferroptosis
inflammatory arthritis
iron accumulation
lipid peroxidation
cell death
title Ferroptosis in inflammatory arthritis: A promising future
title_full Ferroptosis in inflammatory arthritis: A promising future
title_fullStr Ferroptosis in inflammatory arthritis: A promising future
title_full_unstemmed Ferroptosis in inflammatory arthritis: A promising future
title_short Ferroptosis in inflammatory arthritis: A promising future
title_sort ferroptosis in inflammatory arthritis a promising future
topic ferroptosis
inflammatory arthritis
iron accumulation
lipid peroxidation
cell death
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.955069/full
work_keys_str_mv AT siyuanchang ferroptosisininflammatoryarthritisapromisingfuture
AT mengshitang ferroptosisininflammatoryarthritisapromisingfuture
AT bikuizhang ferroptosisininflammatoryarthritisapromisingfuture
AT daxiongxiang ferroptosisininflammatoryarthritisapromisingfuture
AT fenli ferroptosisininflammatoryarthritisapromisingfuture